The markets surged to close sharply with the Dow leaping 144 points to 21,528 as crude oil prices advanced. Nasdaq jumped 87 points to 6,239.
On the upside
Speculation that Amazon (Nasdaq: AMZN) may strike a deal with Rite Aid (NYSE: RAD) to enter the pharmacy market lifted shares of the drug store chain.
Clovis Oncology (Nasdaq: CLVS) reported positive data from a Phase 3 ARIEL3 trial of rucaparib to treat ovarian cancer.
An independent radiology review committee confirmed upbeat results from Exelixis' (Nasdaq: EXEL) Phase 2 trial of cabozantinib.
On the downside
Shares of Fairmount Santrol Holdings (NYSE: FMSA) extended its losses.
Profit taking weighed down shares of Antero Resources (NYSE: AR).
New options for Range Resources (Nasdaq: RRC) began trading today.
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by more than 2 to 1 on Nasdaq. The broader S&P 500 leaped 20 points to 2,453. Bitcoin soared $50 to $2589.
